DENTSPLY SIRONA (XRAY) Ratios
DENTSPLY SIRONA Ratios
MX:XRAY's free cash flow for Q2 2026 was $55.00M. For the 2026 fiscal year, MX:XRAY's free cash flow was decreased by $-44.00M and operating cash flow was $99.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.51 | 1.10 | 1.38 | 1.62 | 1.47 |
| Quick Ratio | 1.03 | 0.74 | 0.95 | 1.08 | 1.06 |
| Cash Ratio | 0.24 | 0.17 | 0.23 | 0.31 | 0.27 |
| Solvency Ratio | -0.06 | -0.15 | 0.05 | -0.16 | 0.18 |
| Operating Cash Flow Ratio | 0.17 | 0.29 | 0.26 | 0.44 | 0.52 |
| Short-Term Operating Cash Flow Coverage | 0.65 | 0.84 | 1.17 | 4.38 | 3.61 |
| Net Current Asset Value | $ -2.07B | $ -2.06B | $ -2.10B | $ -1.94B | $ -2.39B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.45 | 0.39 | 0.31 | 0.28 | 0.25 |
| Debt-to-Equity Ratio | 1.84 | 1.17 | 0.70 | 0.56 | 0.46 |
| Debt-to-Capital Ratio | 0.65 | 0.54 | 0.41 | 0.36 | 0.31 |
| Long-Term Debt-to-Capital Ratio | 0.60 | 0.45 | 0.35 | 0.32 | 0.28 |
| Financial Leverage Ratio | 4.05 | 2.96 | 2.24 | 2.01 | 1.85 |
| Debt Service Coverage Ratio | -0.35 | -0.80 | 0.72 | -3.04 | 3.37 |
| Interest Coverage Ratio | 2.86 | -12.74 | -1.05 | -14.42 | 9.97 |
| Debt to Market Cap | 1.04 | 0.55 | 0.28 | 0.28 | 0.17 |
| Interest Debt Per Share | 12.82 | 11.52 | 11.23 | 10.26 | 10.78 |
| Net Debt to EBITDA | -46.57 | -3.86 | 7.89 | -2.69 | 2.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.00% | 51.62% | 52.61% | 54.23% | 55.47% |
| EBIT Margin | -10.82% | -22.86% | -2.37% | -25.24% | 14.32% |
| EBITDA Margin | -1.25% | -13.66% | 6.28% | -16.88% | 22.50% |
| Operating Profit Margin | 6.85% | -23.17% | -2.14% | -23.89% | 14.37% |
| Pretax Profit Margin | -13.21% | -24.68% | -4.41% | -26.90% | 12.88% |
| Net Profit Margin | -16.25% | -23.99% | -3.33% | -24.22% | 9.71% |
| Continuous Operations Profit Margin | -16.25% | -23.99% | -3.33% | -24.22% | 9.71% |
| Net Income Per EBT | 123.05% | 97.22% | 75.43% | 90.05% | 75.41% |
| EBT Per EBIT | -192.86% | 106.48% | 205.88% | 112.59% | 89.64% |
| Return on Assets (ROA) | -11.01% | -15.82% | -1.79% | -12.43% | 4.45% |
| Return on Equity (ROE) | -44.63% | -46.86% | -4.01% | -24.93% | 8.23% |
| Return on Capital Employed (ROCE) | 6.17% | -21.11% | -1.43% | -14.48% | 7.62% |
| Return on Invested Capital (ROIC) | 5.67% | -17.96% | -1.01% | -12.70% | 5.58% |
| Return on Tangible Assets | -18.08% | -30.86% | -4.09% | -31.13% | 13.96% |
| Earnings Yield | -26.24% | -23.60% | -1.75% | -13.85% | 3.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.35 | 6.26 | 5.24 | 5.73 | 5.27 |
| Payables Turnover | 6.13 | 7.61 | 6.16 | 6.43 | 7.19 |
| Inventory Turnover | 2.87 | 3.25 | 3.01 | 2.86 | 3.66 |
| Fixed Asset Turnover | 3.68 | 4.21 | 4.05 | 4.08 | 4.36 |
| Asset Turnover | 0.68 | 0.66 | 0.54 | 0.51 | 0.46 |
| Working Capital Turnover Ratio | 8.79 | 10.76 | 6.24 | 5.97 | 8.32 |
| Cash Conversion Cycle | 136.08 | 122.56 | 131.56 | 134.51 | 118.29 |
| Days of Sales Outstanding | 68.24 | 58.32 | 69.59 | 63.75 | 69.27 |
| Days of Inventory Outstanding | 127.35 | 112.19 | 121.21 | 127.50 | 99.77 |
| Days of Payables Outstanding | 59.51 | 47.94 | 59.25 | 56.73 | 50.76 |
| Operating Cycle | 195.59 | 170.50 | 190.81 | 191.25 | 169.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.18 | 2.27 | 1.78 | 2.40 | 3.01 |
| Free Cash Flow Per Share | 0.52 | 1.38 | 1.08 | 1.71 | 2.36 |
| Dividend Paid and CapEx Coverage Ratio | 0.91 | 1.51 | 1.42 | 2.04 | 2.81 |
| Capital Expenditure Coverage Ratio | 1.79 | 2.56 | 2.53 | 3.47 | 4.63 |
| Operating Cash Flow Coverage Ratio | 0.10 | 0.20 | 0.16 | 0.24 | 0.29 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.12 | 0.10 | 0.13 | 0.16 |
| Free Cash Flow Yield | 4.56% | 7.29% | 3.02% | 5.36% | 4.23% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.81 | -4.24 | -57.16 | -7.22 | 29.65 |
| Price-to-Sales (P/S) Ratio | 0.62 | 1.02 | 1.90 | 1.75 | 2.88 |
| Price-to-Book (P/B) Ratio | 1.70 | 1.99 | 2.29 | 1.80 | 2.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 21.91 | 13.73 | 33.09 | 18.65 | 23.66 |
| Price-to-Operating Cash Flow Ratio | 9.70 | 8.37 | 20.01 | 13.27 | 18.55 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | -0.01 | 0.67 | 0.02 | -0.05 |
| Enterprise Value Multiple | -96.11 | -11.31 | 38.19 | -13.06 | 14.85 |
| Enterprise Value | 4.42B | 5.86B | 9.51B | 8.64B | 14.14B |
| EV to EBITDA | -96.11 | -11.31 | 38.19 | -13.06 | 14.85 |
| EV to Sales | 1.20 | 1.54 | 2.40 | 2.20 | 3.34 |
| EV to Free Cash Flow | 42.51 | 20.84 | 41.71 | 23.49 | 27.46 |
| EV to Operating Cash Flow | 18.81 | 12.70 | 25.23 | 16.72 | 21.52 |
| Tangible Book Value Per Share | -3.92 | -4.24 | -4.00 | -3.61 | -5.94 |
| Shareholders’ Equity Per Share | 6.72 | 9.56 | 15.53 | 17.68 | 22.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.23 | 0.03 | 0.25 | 0.10 | 0.25 |
| Revenue Per Share | 18.46 | 18.67 | 18.70 | 18.20 | 19.37 |
| Net Income Per Share | -3.00 | -4.48 | -0.62 | -4.41 | 1.88 |
| Tax Burden | 1.23 | 0.97 | 0.75 | 0.90 | 0.75 |
| Interest Burden | 1.22 | 1.08 | 1.86 | 1.07 | 0.90 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 |
| SG&A to Revenue | 0.39 | 0.42 | 0.41 | 0.41 | 0.37 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Income Quality | -0.39 | -0.51 | -2.86 | -0.54 | 1.60 |
Currency in USD